Vial, a global tech-first CRO providing next-generation clinical trial management services, announced it will be presenting at the 2023 Life Sciences Summit hosted by...
Biotech Acquisition Company, a publicly traded special purpose acquisition company affiliated with SPRIM Global Investments, and Blade Therapeutics, Inc. ("Blade"), a biopharmaceutical company based...
Biotech Acquisition Company, a publicly traded special purpose acquisition company affiliated with SPRIM Global Investments, and Blade Therapeutics, Inc. ("Blade"), a biopharmaceutical company based...
Eat Well Investment Group Inc. (“Eat Well” or the “Company”) announces that its principal regulator, the British Columbia Securities Commission, has accepted the Company’s...
Angelini Pharma, international pharmaceutical company part of the privately held Italian Angelini Group announced that ONTOZRY® (cenobamate) is now available in the Netherlands for...
